Shamburg News · 8-K filed Oct 1, 2026, 5:15 PM EDT

Pelthos Therapeutics Stockholders Elect Eight Directors and Approve 2026 Equity Incentive Plan

PTHS · Pelthos Therapeutics Inc.

  • Shareholder vote
  • Other event
  • Materiality: low

At its 2026 Annual Meeting on September 29, 2026, Pelthos Therapeutics Inc. stockholders elected eight director nominees to serve until the 2027 annual meeting and ratified Grant Thornton LLP as independent registered public accounting firm for fiscal 2026. Stockholders also approved the Pelthos Therapeutics Inc. 2026 Equity Incentive Plan, which replaces the 2023 Equity Incentive Plan, as amended and restated, and the plan became effective upon approval. A quorum was present, representing 70.0% of the voting power as of the August 4, 2026 record date.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 5.02, 5.07, 9.01, accession 0001919246-26-000125.

Written from the filing by Shamburg Markets. Figures are as reported by the company.